Table 3.
Ref.
|
Proportion
|
Cumulative incidence
|
Median follow-up
|
Patients
|
Cui et al[59] | 20/81 (25%) | NR | NR | ICU patients |
Klok et al[60] | 68/184 (37%) | 57% or 49% adjusted for competing risk of death | 14 d | ICU patients only.19 PE were limited to subsegmental arteries.65/68 venous events were PE (95.6%) |
Poissy et al[61] | VTE 22.2% of 54 ICU admitted | |||
Helms et al[44] | 27/150 (18%) | NR | NR | ICU patients with ARDS 25/27 events were PE (92.5%) |
Poissy et al[61] | PE only 22/107 (20.6%) | 20.4% calculated at ICU day 15 | 6 d | ICU only |
Middeldorp et al[63] | Venous thromboembolism 39% of COVID-19 ICU cases 74 patients | |||
Llitjos et al[64] | DVT: 18/26 (69%); PE: 6/26 (23%) | NR | NR | ICU patients. Systematic ultrasound screening |
Léonard-Lorant et al[183] | PE only 32/106 (30%) | NR | NR | 24/32 (75%) PE-positive patients were in the ICU |
Grillet et al[184] | PE only 23/100 (23%) | NR | NR | Ward: 6/61 (9.8%); ICU: 17/39 (43.6%) |
Middeldorp et al[63] | 33/198 (17%) | 15% at 7 d; 34% at 14 d | 5 d | Ward: 4/123 (3.3%); ICU: 35/75 (47%); 11 (5.4%) clots detected on screening 11/33 events were PE (33%) |
Lodigiani et al[185] | 16/362 (4.4%) | 21% (time not reported) | 10 d | ICU 4/48(8.3%); Ward 12/314 (3.8%) |
Thomas et al[186] | 6/63 (9%) | 27% | 8 d | ICU patients |
Cattaneo et al[108] | DVT only 0/388 (0%) | NR | NR | Non-ICU Ward 64 patients had screening ultrasound. All negative |
DVT: Deep vein thrombosis; ICU: Intensive care unit; NR: Not reported; PE: Pulmonary embolism.